BTSG BRIGHTSPRING HEALTH SVCS INC revenue, earnings and financials
For the quarter ended June 30, 2026, BRIGHTSPRING HEALTH SVCS INC reported revenue of $3.87B (up 23.0% from a year earlier), net income of $84.3M and diluted EPS of $0.38; over the last four quarters revenue was $14.4B and net income $364M; for the fiscal year ended December 2025 revenue was $12.9B, up 28.2% on the year before.
BTSG annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $12.9B, gross profit $1.52B, operating income $295M, net income $189M (margin 1.5%), EPS $0.87
- Fiscal year ended Dec 2024: revenue $10.1B, gross profit $1.27B, operating income $108M, net income $20.5M (margin 0.2%), EPS −$0.09
- Fiscal year ended Dec 2023: revenue $7.69B, gross profit $1.14B, operating income $58.1M, net income −$155M (margin -2.0%), EPS −$1.31
- Fiscal year ended Dec 2022: revenue $6.64B, gross profit $1.08B, operating income $119M, net income −$53.9M (margin -0.8%), EPS −$0.46
BTSG quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $3.87B (up 23.0% year over year), net income $84.3M, EPS $0.38
- Quarter ended Mar 31, 2026: revenue $3.61B (up 25.6% year over year), net income $149M, EPS $0.67
- Quarter ended Dec 31, 2025 (from the annual report): revenue $3.55B (up 91.0% year over year), net income $75.5M, EPS $0.34
- Quarter ended Sep 30, 2025: revenue $3.33B (up 14.7% year over year), net income $55.8M, EPS $0.26
- Quarter ended Jun 30, 2025: revenue $3.15B (up 15.3% year over year), net income $28.2M, EPS $0.13
- Quarter ended Mar 31, 2025: revenue $2.88B (up 11.7% year over year), net income $29.5M, EPS $0.14
- Quarter ended Dec 31, 2024 (from the annual report): revenue $1.86B (up 50.0% year over year), net income $54.6M, EPS $0.11
- Quarter ended Sep 30, 2024: revenue $2.91B (up 28.8% year over year), net income −$8.23M, EPS −$0.04
- Quarter ended Jun 30, 2024: revenue $2.73B (up 26.0% year over year), net income $19.9M, EPS $0.10
- Quarter ended Mar 31, 2024: revenue $2.58B (up 27.0% year over year), net income −$45.8M, EPS −$0.26
- Quarter ended Dec 31, 2023 (from the annual report): revenue $1.24B, net income −$6.54M, EPS −$0.05
- Quarter ended Sep 30, 2023: revenue $2.26B, net income −$131M, EPS −$1.11
- Quarter ended Jun 30, 2023: revenue $2.17B, net income $3.99M, EPS $0.03
- Quarter ended Mar 31, 2023: revenue $2.03B, net income −$21.4M, EPS −$0.18
BTSG cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $490M, share buybacks $43.2M
- Fiscal year ended Dec 2024: operating cash flow $23.8M, share buybacks $650K
- Fiscal year ended Dec 2023: operating cash flow $211M, share buybacks $650K
- Fiscal year ended Dec 2022: operating cash flow −$4.65M, share buybacks n/a
BTSG balance sheet
- Jun 30, 2026: cash $550M, total assets $5.99B, total liabilities $3.93B, shareholders' equity $2.05B, long-term debt $2.15B
- Mar 31, 2026: cash $889M, total assets $6.21B, total liabilities $4.22B, shareholders' equity $1.98B, long-term debt $2.44B
- Dec 31, 2025: cash $88.4M, total assets $6.41B, total liabilities $4.53B, shareholders' equity $1.88B, long-term debt $2.46B
- Sep 30, 2025: cash $140M, total assets $6.05B, total liabilities $4.23B, shareholders' equity $1.82B, long-term debt $2.47B
- Jun 30, 2025: cash $70.1M, total assets $5.94B, total liabilities $4.20B, shareholders' equity $1.74B, long-term debt $2.48B
- Mar 31, 2025: cash $52.3M, total assets $5.85B, total liabilities $4.16B, shareholders' equity $1.69B, long-term debt $2.49B
- Dec 31, 2024: cash $61.0M, total assets $5.93B, total liabilities $4.27B, shareholders' equity $1.65B, long-term debt $2.56B
- Sep 30, 2024: cash $36.0M, total assets $5.79B, total liabilities $4.17B, shareholders' equity $1.61B, long-term debt $2.61B
What is BTSG's revenue?
BRIGHTSPRING HEALTH SVCS INC reported $14.4B of revenue over its last four quarters, through June 30, 2026.
Is BTSG profitable?
Yes. BRIGHTSPRING HEALTH SVCS INC earned $364M over the last four quarters.
What is BTSG's EPS?
Diluted earnings per share over the last four quarters were $1.65; $0.38 in the latest quarter.